Mankind Pharma Overview
- Year Founded
-
1991
- Status
-
Public
- Employees
-
20,428
- Stock Symbol
-
543904
- Investments
-
25
- Share Price
-
$28.22
- (As of Friday Closing)
Mankind Pharma General Information
Description
Mankind Pharma Ltd is principally engaged in the manufacturing and trading of pharmaceuticals and health care products. The company develops, manufactures and markets pharmaceutical formulations across a wide spectrum of acute and chronic therapeutic areas, and consumer healthcare segment, which provides international quality products. It has one reportable segment Pharmaceuticals. It has presence in India, and Outside India. The company generates majority of revenue from India.
Contact Information
Website
www.mankindpharma.comCorporate Office
- 262, Okhla Industrial Estate
- Phase-III
- New Delhi, Delhi 110020
- India
Corporate Office
- 262, Okhla Industrial Estate
- Phase-III
- New Delhi, Delhi 110020
- India
Mankind Pharma Stock Performance
As of 13-Nov-2026, Mankind Pharma’s stock price is $28.22. Its current market cap is $11.7B with 413M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $28.22 | $28.12 | $20.38 - $28.80 | $11.7B | 413M | 53.1K | $0.59 |
Mankind Pharma Financials Summary
As of 30-Sep-2026, Mankind Pharma has a trailing 12-month revenue of $1.66B.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 11,227,782 | 9,275,988 | 11,193,774 | 10,803,253 |
| Revenue | 1,658,622 | 1,615,780 | 1,443,690 | 1,239,256 |
| EBITDA | 462,441 | 429,385 | 412,801 | 336,338 |
| Net Income | 241,875 | 216,484 | 235,457 | 231,066 |
| Total Assets | 3,014,471 | 2,976,021 | 3,245,237 | 1,434,554 |
| Total Debt | 564,457 | 668,931 | 995,034 | 24,842 |
Mankind Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Mankind Pharma Comparisons
Industry
Financing
Details
Mankind Pharma Competitors (14)
One of Mankind Pharma’s 14 competitors is Natco Pharma, a Corporation company based in Hyderabad, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Natco Pharma | Corporation | Hyderabad, India | ||||
| Lupin | Corporation | Mumbai, India | ||||
| Zuellig Pharma | Formerly VC-backed | Singapore, Singapore | ||||
| Granules India | Corporation | Hyderabad, India | ||||
| Cipla | Corporation | Mumbai, India |
Mankind Pharma Patents
Mankind Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026041965-A1 | Bicyclic imidazo-thiadiazole grp119 agonist compounds | Pending | 22-Aug-2024 | ||
| WO-2026038151-A1 | Use of gpr119 agonists for the treatment of metabolic-related disorders | Pending | 14-Aug-2024 | ||
| WO-2026038132-A1 | Use of gpr119 agonists for the treatment of weight related disorders | Pending | 12-Aug-2024 | ||
| AU-2024325564-A1 | Improved processes for the preparation and purification of gpr119 agonist compounds and intermediates thereof | Pending | 11-Aug-2023 | ||
| AU-2024324576-A1 | Pharmaceutical formulations of gpr119 agonists and uses thereof | Pending | 11-Aug-2023 | A61K31/506 |
Mankind Pharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Mankind Pharma Investments & Acquisitions (25)
Mankind Pharma’s most recent deal was a Merger/Acquisition with Armed Cell Therapeutics for . The deal was made on 15-Oct-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Armed Cell Therapeutics | 15-Oct-2026 | Merger/Acquisition | Drug Discovery | ||
| BatX Energies | 02-Jul-2026 | Later Stage VC | Environmental Services (B2B) | ||
| Finfinity | 23-Mar-2026 | Seed Round | Financial Software | ||
| Roche (Rivotril Brand in India) | 18-Mar-2026 | Corporate Asset Purchase | Buildings and Property | ||
| Innov8 (Buildings and Property) | 07-Jan-2025 | PE Growth/Expansion | Buildings and Property |
Mankind Pharma ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
32.31 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Pharmaceuticals
Subindustry
of 354
Rank
Percentile
Mankind Pharma Exits (1)
Mankind Pharma’s most recent exit was on 23-Oct-2024 from Bharat Serums and Vaccines. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Bharat Serums and Vaccines | 23-Oct-2024 | Completed |
|
Mankind Pharma Affiliates
Subsidiaries (4)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Upakarma Ayurveda | Delhi, India | 2017 | |
| Pathkind Diagnostics | Gurugram, India | 2017 | |
| Bharat Serums and Vaccines | Navi Mumbai, India | 1971 | |
| Lifestar Pharma | Tucson, AZ |
Mankind Pharma FAQs
-
When was Mankind Pharma founded?
Mankind Pharma was founded in 1991.
-
Where is Mankind Pharma headquartered?
Mankind Pharma is headquartered in New Delhi, India.
-
What is the size of Mankind Pharma?
Mankind Pharma has 20,428 total employees.
-
What industry is Mankind Pharma in?
Mankind Pharma’s primary industry is Pharmaceuticals.
-
Is Mankind Pharma a private or public company?
Mankind Pharma is a Public company.
-
What is Mankind Pharma’s stock symbol?
The ticker symbol for Mankind Pharma is 543904.
-
What is the current stock price of Mankind Pharma?
As of 13-Nov-2026 the stock price of Mankind Pharma is $28.22.
-
What is the current market cap of Mankind Pharma?
The current market capitalization of Mankind Pharma is $11.7B.
-
What is Mankind Pharma’s current revenue?
The trailing twelve month revenue for Mankind Pharma is $1.66B.
-
Who are Mankind Pharma’s competitors?
Natco Pharma, Lupin, Zuellig Pharma, Granules India, and Cipla are some of the 14 competitors of Mankind Pharma.
-
What is Mankind Pharma’s annual earnings per share (EPS)?
Mankind Pharma’s EPS for 12 months was $0.59.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
